A Trial to Evaluate the Effect of Rosuvastatin on Inflammation in Patients Undergoing Isolated Cardiac Valve Surgery
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
High-dose statin therapy around the time of surgery, decreases inflammation in patients
undergoing cardiac valve surgery, and thereby improves clinical outcomes.
Phase:
Phase 3
Details
Lead Sponsor:
McGill University Health Center McGill University Health Centre/Research Institute of the McGill University Health Centre